149 related articles for article (PubMed ID: 17543436)
41. Transcellular transport of aconitine across human intestinal Caco-2 cells.
Yang C; Li Z; Zhang T; Liu F; Ruan J; Zhang Z
Food Chem Toxicol; 2013 Jul; 57():195-200. PubMed ID: 23562926
[TBL] [Abstract][Full Text] [Related]
42. Multidrug-resistant tumor cells remain sensitive to a recombinant interleukin-4-Pseudomonas exotoxin, except when overexpressing the multidrug resistance protein MRP1.
de Jong MC; Scheffer GL; Broxterman HJ; Hooijberg JH; Slootstra JW; Meloen RH; Kreitman RJ; Husain SR; Joshi BH; Puri RK; Scheper RJ
Clin Cancer Res; 2003 Oct; 9(13):5009-17. PubMed ID: 14581376
[TBL] [Abstract][Full Text] [Related]
43. Transport of dietary phenethyl isothiocyanate is mediated by multidrug resistance protein 2 but not P-glycoprotein.
Ji Y; Morris ME
Biochem Pharmacol; 2005 Aug; 70(4):640-7. PubMed ID: 16002050
[TBL] [Abstract][Full Text] [Related]
44. Intestinal expression of P-glycoprotein (ABCB1), multidrug resistance associated protein 2 (ABCC2), and uridine diphosphate-glucuronosyltransferase 1A1 predicts the disposition and modulates the effects of the cholesterol absorption inhibitor ezetimibe in humans.
Oswald S; Haenisch S; Fricke C; Sudhop T; Remmler C; Giessmann T; Jedlitschky G; Adam U; Dazert E; Warzok R; Wacke W; Cascorbi I; Kroemer HK; Weitschies W; von Bergmann K; Siegmund W
Clin Pharmacol Ther; 2006 Mar; 79(3):206-17. PubMed ID: 16513445
[TBL] [Abstract][Full Text] [Related]
45. Assessment and modulation of forsythiaside absorption with MDCKII cells and validation with in situ intestinal experiment.
Li YX; Zhang RQ; Peng C
Eur J Drug Metab Pharmacokinet; 2012 Sep; 37(3):179-86. PubMed ID: 22430364
[TBL] [Abstract][Full Text] [Related]
46. Paclitaxel-2'-Ethylcarbonate prodrug can circumvent P-glycoprotein-mediated cellular efflux to increase drug cytotoxicity.
Tanino T; Nawa A; Kondo E; Kikkawa F; Daikoku T; Tsurumi T; Luo C; Nishiyama Y; Takayanagi Y; Nishimori K; Ichida S; Wada T; Miki Y; Iwaki M
Pharm Res; 2007 Mar; 24(3):555-65. PubMed ID: 17245652
[TBL] [Abstract][Full Text] [Related]
47. Interaction of ochratoxin A with human intestinal Caco-2 cells: possible implication of a multidrug resistance-associated protein (MRP2).
Berger V; Gabriel AF; Sergent T; Trouet A; Larondelle Y; Schneider YJ
Toxicol Lett; 2003 Apr; 140-141():465-76. PubMed ID: 12676495
[TBL] [Abstract][Full Text] [Related]
48. MK571 inhibits phase-2 conjugation of flavonols by Caco-2/TC7 cells, but does not specifically inhibit their apical efflux.
Barrington RD; Needs PW; Williamson G; Kroon PA
Biochem Pharmacol; 2015 Jun; 95(3):193-200. PubMed ID: 25801004
[TBL] [Abstract][Full Text] [Related]
49. Species-dependent transport and modulation properties of human and mouse multidrug resistance protein 2 (MRP2/Mrp2, ABCC2/Abcc2).
Zimmermann C; van de Wetering K; van de Steeg E; Wagenaar E; Vens C; Schinkel AH
Drug Metab Dispos; 2008 Apr; 36(4):631-40. PubMed ID: 18180270
[TBL] [Abstract][Full Text] [Related]
50. Avermectin transepithelial transport in MDR1- and MRP-transfected canine kidney monolayers.
Brayden DJ; Griffin J
Vet Res Commun; 2008 Jan; 32(1):93-106. PubMed ID: 17578674
[TBL] [Abstract][Full Text] [Related]
51. Carrier-Mediated and Energy-Dependent Uptake and Efflux of Deoxynivalenol in Mammalian Cells.
Li X; Mu P; Wen J; Deng Y
Sci Rep; 2017 Jul; 7(1):5889. PubMed ID: 28725050
[TBL] [Abstract][Full Text] [Related]
52. Commonly used nonionic surfactants interact differently with the human efflux transporters ABCB1 (p-glycoprotein) and ABCC2 (MRP2).
Hanke U; May K; Rozehnal V; Nagel S; Siegmund W; Weitschies W
Eur J Pharm Biopharm; 2010 Oct; 76(2):260-8. PubMed ID: 20600890
[TBL] [Abstract][Full Text] [Related]
53. Cellular uptake and efflux of trans-piceid and its aglycone trans-resveratrol on the apical membrane of human intestinal Caco-2 cells.
Henry C; Vitrac X; Decendit A; Ennamany R; Krisa S; Mérillon JM
J Agric Food Chem; 2005 Feb; 53(3):798-803. PubMed ID: 15686436
[TBL] [Abstract][Full Text] [Related]
54. Data-based mathematical modeling of vectorial transport across double-transfected polarized cells.
Bartholomé K; Rius M; Letschert K; Keller D; Timmer J; Keppler D
Drug Metab Dispos; 2007 Sep; 35(9):1476-81. PubMed ID: 17548463
[TBL] [Abstract][Full Text] [Related]
55. Effect of ion-pair formation with bile salts on the in vitro cellular transport of berberine.
Chae HW; Kim IW; Jin HE; Kim DD; Chung SJ; Shim CK
Arch Pharm Res; 2008 Jan; 31(1):103-10. PubMed ID: 18277615
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of the selected barrier properties of retinal pigment epithelial cell line ARPE-19 for an in-vitro blood-brain barrier model.
Nevala H; Ylikomi T; Tähti H
Hum Exp Toxicol; 2008 Oct; 27(10):741-9. PubMed ID: 19042959
[TBL] [Abstract][Full Text] [Related]
57. Intestinal permeability and P-glycoprotein-mediated efflux transport of ticagrelor in Caco-2 monolayer cells.
Marsousi N; Doffey-Lazeyras F; Rudaz S; Desmeules JA; Daali Y
Fundam Clin Pharmacol; 2016 Dec; 30(6):577-584. PubMed ID: 27416295
[TBL] [Abstract][Full Text] [Related]
58. The potential role of human multidrug resistance protein 1 (MDR1) and multidrug resistance-associated protein 2 (MRP2) in the transport of Huperzine A
Fei Z; Hu M; Baum L; Kwan P; Hong T; Zhang C
Xenobiotica; 2020 Mar; 50(3):354-362. PubMed ID: 31132291
[TBL] [Abstract][Full Text] [Related]
59. Kinetic validation of the use of carboxydichlorofluorescein as a drug surrogate for MRP5-mediated transport.
Pratt S; Chen V; Perry WI; Starling JJ; Dantzig AH
Eur J Pharm Sci; 2006 Apr; 27(5):524-32. PubMed ID: 16337112
[TBL] [Abstract][Full Text] [Related]
60. MRP2-mediated transport of etoposide in MDCKII MRP2 cells is unaffected by commonly used non-ionic surfactants.
Nielsen S; Westerhoff AM; Gé LG; Carlsen KL; Pedersen MDL; Nielsen CU
Int J Pharm; 2019 Jun; 565():306-315. PubMed ID: 31085259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
